ANA Therapeutics is a seed startup based in United States. 1 investor tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
ANA Therapeutics is a biopharmaceutical company developing first-in-class drugs that target a newly discovered, validated metabolic vulnerability present in cancer cells.
Stage
seed
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky